Shattuck Labs (STTK)
(Real Time Quote from BATS)
$3.63 USD
-0.07 (-1.89%)
Updated Sep 25, 2024 01:22 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Brokerage Reports
0 items in cart
Shattuck Labs, Inc. [STTK]
Reports for Purchase
Showing records 1 - 20 ( 32 total )
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
2Q24 Results; Enrollment Continues in Phase 1b 1L HRMDS Dose Expansion Cohort
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
SL-172154 Continues to Rise to The Top in CD47 Space; Target Adjusted to $16
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
Encouraging Early Update From SL-172154 in HRMDS/ TP53m AML
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
1Q24 Results; Key Data Readouts Forthcoming Across SL-172154 Program; Updated MDS/AML Phase 1b Results at EHA
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
AACR Comp Highlights the Potential of Combining CD47 Blockades With Costimulation in HR-MDS
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
Combating CKI Resistance Through Novel Target, TRIM7; AACR Data Showcase Broadening Oncology Pipeline
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
2023 Results; Mid-2024 Brings Abundant Data Readouts Across Various Indications For SL-172154
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
Early BD Interest From Ono Highlights Shattuck''s Construction Capabilities of Multifunctional Compounds
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
SL-172154 Focus Piece; All Eyes On Upcoming Readouts in Frontline MDS/AML; Potential First to Market Opportunity
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
2024 Top Picks: Seeing Important Turnaround Year While Watching the Macro
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
2024 Top Picks: Seeing Important Turnaround Year While Watching the Macro
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
Key Data Updates Across SL-172154 Program Set the Stage For 1H24; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
154 Hitting Nice Stride; Strong Early Promise in Frontline TP53+ AML and HR-MDS; Next Readout Mid-2024
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
ASH Presentation Highlights Encouraging Initial Profile For SL-17254 in r/r AML/HR-MDS
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
3Q23 Results; Encouraging Early Readouts Continue; Positive Interim Data From SL-172154 in Phase 1 PROC Study
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
First Look at SL-172154 Shows Encouraging Signs of Anti-Leukemic Activity; Full Presentation at ASH
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
2Q23 Results; All Eyes on SL-172154 as Key Data Readouts Expected 4Q23
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
SL-172154 Potential Demonstrated in PROC Phase 1a Dose-Escalation Study at ASCO
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
SL-172154 Data Establish Promising Foothold in PROC; Full Presentation at ASCO
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
1Q23 Results; All Eyes on SL-172154's Key Data Readouts for PROC and AML/HR-MDS in 2023
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J